Your browser doesn't support javascript.
loading
Aflibercept more effectively weans patients with neovascular age-related macular degeneration off therapy compared with bevacizumab.
Cao, Xuan; Sanchez, Jaron Castillo; Patel, Tapan P; Yang, Zhiyong; Guo, Chuanyu; Malik, Danyal; Sopeyin, Anuoluwapo; Montaner, Silvia; Sodhi, Akrit.
Afiliação
  • Cao X; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Sanchez JC; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Patel TP; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Yang Z; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Guo C; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Malik D; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Sopeyin A; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Montaner S; Department of Oncology and Diagnostic Sciences, School of Dentistry, Department of Pathology, School of Medicine, University of Maryland School of Dentistry, Baltimore, Maryland, USA; Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.
  • Sodhi A; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
J Clin Invest ; 133(2)2023 01 17.
Article em En | MEDLINE | ID: mdl-36413411
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Degeneração Macular Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Degeneração Macular Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article